arrow
D

Dalong Zhu

南京大学
H指数:42
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial

cAMP信号偏向的GLP-1类似物ecnoglutide单药治疗与安慰剂在2型糖尿病患者中的疗效和安全性(EECOH-1):一项多中心、随机、双盲、安慰剂对照、III期试验

2026-01-070
OAAI
Mazdutide versus placebo in Chinese adults with type 2 diabetes

Mazdutide 与安慰剂在中国 2 型糖尿病成人中的比较

Nature
IF48.5
2025-12-170
PRE
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function

非奈利酮在亚洲2型糖尿病合并慢性肾脏病患者中的有效性与安全性:基于基线肾功能分析的FIDELITY研究

2025-11-040
PRE
Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study

中国糖尿病患者中慢性肾脏病的患病率:一项全国性基于人群的横断面研究

2025-02-013
OAAI
Effectiveness and Safety of the TRIO Optimal Health Management Program in Patients With Type 2 Diabetes Mellitus Initiating Basal Insulin Therapy: Prospective Observational Real-World Study

TRIO优化健康管理计划在开始基础胰岛素治疗的2型糖尿病患者中的有效性和安全性: 前瞻性观察性真实世界研究

2025-01-130
OA